GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
The current price of WGS is $66.04 USD — it has increased by +2.83% in the past 24 hours. Watch GeneDx stock price performance more closely on the chart.
What is GeneDx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange GeneDx stocks are traded under the ticker WGS.
Is GeneDx stock price growing?▼
WGS stock has fallen by -1.81% compared to the previous week, the month change is a -17.53% fall, over the last year GeneDx has showed a -22.28% decrease.
What is GeneDx market cap?▼
Today GeneDx has the market capitalization of 1.93B
When is the next GeneDx earnings date?▼
GeneDx is going to release the next earnings report on May 13, 2026.
What were GeneDx earnings last quarter?▼
WGS earnings for the last quarter are 0.14 USD per share, whereas the estimation was 0.1 USD resulting in a +36.8% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GeneDx revenue for the last year?▼
GeneDx revenue for the last year amounts to 855.08M USD.
What is GeneDx net income for the last year?▼
WGS net income for the last year is -42.04M USD.
How many employees does GeneDx have?▼
As of April 01, 2026, the company has 1,000 employees.
In which sector is GeneDx located?▼
GeneDx operates in the Health Care sector.
When did GeneDx complete a stock split?▼
The last stock split for GeneDx was on May 04, 2023 with a ratio of 1:33.